Ovoca Bio PLC (LSE:OVB) - Share price


Stock Report

Ovoca Bio PLC OVB

Latest Morningstar Commentary
DateAuthor Headline

Latest Company News

DateTimeSourceHeadlineType
Previous Stories...
07/11/201912:45LSEAttendance at Bio-Europe ConferenceNRA
16/09/201907:00LSEInterim ResultsIR
12/09/201907:00LSEFiling of Marketing Authorisation ApplicationRAP
28/08/201907:00LSEDirectorate ChangeBOA
08/08/201916:14LSEResult of AGMRAG
08/08/201909:05LSESecond Price Monitoring ExtnAPM
08/08/201909:00LSEPrice Monitoring ExtensionPME
08/08/201907:00LSEAGM StatementAGM
26/07/201907:00LSEDirectorate ChangeBOA
25/07/201916:41LSESecond Price Monitoring ExtnAPM
25/07/201916:35LSEPrice Monitoring ExtensionPME
28/06/201907:00LSEAnnual Report and Notice of AGMACS
23/04/201907:00LSEUS and EU Clinical Development PlansMSC
29/03/201907:00LSEDirector/PDMR ShareholdingDSH
27/03/201907:00LSEOperational Update & Additional Investment in IVIXUPD
25/03/201907:00LSEPrimary Endpoints Met in Libicore Phase III StudyMSC
31/12/201807:00LSEDirector/PDMR ShareholdingDSH
28/09/201807:00LSEInterim ResultsIR
26/09/201807:00LSECompletion of Acquisition of IVIXACQ
03/08/201807:00LSEChange of Name to Ovoca Bio plcCAN
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.